These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
594 related items for PubMed ID: 15977144
1. Radioiodine treatment of hyperthyroidism in patients with low thyroid uptake. Ruchała M, Sowiński J, Dolata M, Junik R, Gembicki M, Skiba A. Nucl Med Rev Cent East Eur; 2005; 8(1):28-32. PubMed ID: 15977144 [Abstract] [Full Text] [Related]
2. High prevalence of side effects after recombinant human thyrotropin-stimulated radioiodine treatment with 30 mCi in patients with multinodular goiter and subclinical/clinical hyperthyroidism. Romão R, Rubio IG, Tomimori EK, Camargo RY, Knobel M, Medeiros-Neto G. Thyroid; 2009 Sep; 19(9):945-51. PubMed ID: 19678745 [Abstract] [Full Text] [Related]
3. Radioiodine therapy in hyperthyroidism: inverse correlation of pretherapeutic iodine uptake level and post-therapeutic outcome. Walter MA, Christ-Crain M, Eckard B, Schindler C, Nitzsche EU, Müller-Brand J, Müller B. Eur J Clin Invest; 2004 May; 34(5):365-70. PubMed ID: 15147334 [Abstract] [Full Text] [Related]
4. [Radioiodine treatment of hyperthyroidism using a simplified dosimetric approach. Clinical results]. Giovanella L, De Palma D, Ceriani L, Vanoli P, Garancini S, Tordiglione M, Tarolo GL. Radiol Med; 2000 Dec; 100(6):480-3. PubMed ID: 11307510 [Abstract] [Full Text] [Related]
11. Iodine prophylaxis intensification. Influence on radioiodine uptake and activity of 131I used in the treatment of hyperthyroid patients with Graves' disease. Baczyk M, Junik R, Ziemnicka K, Sowiński J. Nuklearmedizin; 2005 Mar; 44(5):197-9. PubMed ID: 16395495 [Abstract] [Full Text] [Related]
12. [Analysis of factors affecting treatment results for toxic goiter with radioactive 131I]. Listewnik MH. Ann Acad Med Stetin; 2000 Mar; 46():109-21. PubMed ID: 11712298 [Abstract] [Full Text] [Related]
15. Safety and efficacy of administering 0.2 mg of recombinant human TSH for two consecutive days as an adjuvant to therapy with low radioiodine doses in elderly out-patients with large nontoxic multinodular goiter. Giusti M, Cappi C, Santaniello B, Ceresola E, Augeri C, Lagasio C, Minuto F. Minerva Endocrinol; 2006 Sep; 31(3):191-209. PubMed ID: 17213787 [Abstract] [Full Text] [Related]